Letter: Oculocutaneous reactions in beta-blocking drugs.
D000974:Antibodies, Antinuclear; D003327:Coronary Disease / Q000276:immunology; D005128:Eye Diseases / Q000139:chemically induced*; D006801:Humans; D011433:Propranolol / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced*
D000974:Antibodies, Antinuclear; D011433:Propranolol